Evidence generation and biostatistics
PROVIDE RIGOROUS METHODOLOGY FOR CLINICAL TRIALS, PRAGMATIC STUDIES, AND REAL-WORLD EVIDENCE.
Our cross-functional experts support clinical development from study design through execution—covering biostatistical methodology, operational strategy, and evidence generation across randomized clinical trials (RCTs), pragmatic trials, and real-world evidence (RWE) studies. We deliver a complete blueprint—from protocol development to operational alignment—so you can ensure methodological rigor, regulatory readiness, and actionable insights.
How We Do It:
Design and analyze clinical and research studies, including randomized, pragmatic, and RWE trials.
Provide end-to-end biostatistical support: study design, sample size and randomization, statistical analysis plans, interim analyses, and interpretation of results with regulatory confidence.
Build evidence generation strategies that connect robust methods with outcomes to support regulatory submissions, payer negotiations, and market access.